CWAN•benzinga•
Clearwater Analytics' Enfusion Infusion Offers Compelling Value Proposition, Analyst Upgrades Stock
Summary
Piper Sandler analyst Arvind Ramnani upgraded Clearwater Analytics to Overweight, increasing the price target to $36 from $28. CWAN's strong Q4 results exceeded revenue expectations, reporting $126.5M, a 27.7% YoY growth.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 20, 2025 by benzinga